Menu
 
Research menu
Jump to menu

Publications:  Prof Rhian Gabe

Dibden A, Offman J, Duffy SW, Gabe R(2020). Worldwide review and meta-analysis of cohort studies measuring the effect of mammography screening programmes on incidence-based breast cancer mortality. Cancers vol. 12, (4)
10.3390/cancers12040976
https://qmro.qmul.ac.uk/xmlui/handle/123456789/64751
Johnson MJ, Cockayne S, Currow DC, Bell K, Hicks K, Fairhurst C, Gabe R, Torgerson D et al.(2019). Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo-controlled trial. ESC Heart Failure vol. 6, (6) 1149-1160.
10.1002/ehf2.12498
https://qmro.qmul.ac.uk/xmlui/handle/123456789/59564
Allgood, MARONI R, Hudson S, Offman, Turnbull AE, Peacock L, Steel J, Kirby G et al.(2017). The effect of second timed appointments for non-attenders of breast cancer screening in England: a randomised controlled trial. Lancet Oncology
10.1016/S1470-2045(17)30340-6
https://qmro.qmul.ac.uk/xmlui/handle/123456789/22345
Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, Collaco-Moraes Y, Ward K et al.(2017). Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. The Lancet vol. 389, (10071) 815-822.
10.1016/s0140-6736(16)32401-1
https://qmro.qmul.ac.uk/xmlui/handle/123456789/64897
Gilbert DC, Al-Saadi R, Thway K, Chandler I, Berney D, Gabe R, Stenning SP, Sweet J et al.(2016). Defining a New Prognostic Index for Stage I Nonseminomatous Germ Cell Tumors Using CXCL12 Expression and Proportion of Embryonal Carcinoma. Clin Cancer Res vol. 22, (5) 1265-1273.
10.1158/1078-0432.CCR-15-1186
Jha V, Buckley H, Gabe R, Kanaan M, Lawton R, Melville C, Quinton N, Symons J et al.(2014). Patients as teachers: a randomised controlled trial on the use of personal stories of harm to raise awareness of patient safety for doctors in training. BMJ Quality & Safety vol. 24, (1) 21-30.
10.1136/bmjqs-2014-002987
Moore KM, Thomas GJ, Duffy SW, Warwick J, Gabe R, Chou P, Ellis IO, Green AR et al.(2014). Therapeutic targeting of integrin αvβ6 in breast cancer. Journal of the National Cancer Institute vol. 106, (8)
10.1093/jnci/dju169
https://qmro.qmul.ac.uk/xmlui/handle/123456789/8829
Cafferty FH, Gabe R, Huddart RA, Rustin G, Williams MP, Stenning SP, Bara A, Bathia R et al.(2012). UK management practices in stage i seminoma and the medical research council trial of imaging and schedule in seminoma testis managed with surveillance. Clinical Oncology vol. 24, (1) 25-29.
10.1016/j.clon.2011.09.005
Oliver RTD, Mead GM, Rustin GJS, Joffe JK, Aass N, Coleman R, Gabe R, Pollock P et al. (2011). Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214). J Clin Oncol. vol. 29, 957-962.
10.1200/JCO.2009.26.4655
Mead GM, Fossa SD, Oliver RTD, Joffe JK, Huddart RA, Roberts JT, Pollock P, Gabe R et al.(2011). Randomized trials in 2466 patients with stage i seminoma: Patterns of relapse and follow-up. Journal of the National Cancer Institute vol. 103, (3) 241-249.
10.1093/jnci/djq525
Duffy SW, Olsen AH, Gabe R, Tabar L, Warwick J, Fielder H, Tryggvadottir L, Agbaje OF(2008). Screening opportunity bias in case-control studies of cancer screening. J APPL STAT vol. 35, (5) 537-546.
10.1080/02664760701835755
Jones JL, Thomas GJ, Duffy SW, Gabe R, Ellis I, Green A, Saha A, Mulligan KT et al. (2007). Expression of alphavbeta6 supersedes Her2 and triple-negative/basal classification of breast cancer and defines novel subgroups with poor survival: implications for breast cancer classification and treatment. BREAST CANCER RESEARCH AND TREATMENT. vol. 106, S11-S11.
Gabe R, Tryggvadóttir L, Sigfússon BF, Olafsdóttir GH, Sigurdsson K, Duffy SW(2007). A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol vol. 48, (9) 948-955.
10.1080/02841850701501725
Duffy SW, Chen THH, Yen AMF, Tabar L, Gabe R, Smith RA(2007). Methodologic Issues in the Evaluation of Service Screening. Seminars in Breast Disease vol. 10, (2) 68-71.
10.1053/j.sembd.2007.09.003
Duffy SW, Jonsson H, Agbaje OF, Pashayan N, Gabe R(2007). Avoiding bias from aggregate measures of exposure. J Epidemiol Community Health vol. 61, (5) 461-463.
10.1136/jech.2006.050203
Warwick J, Duffy S, Gabe R (2006). Evaluating the impact of population-based mammography service screening on breast cancer mortality in Western Europe; recent results and methodological challenges. BREAST CANCER RESEARCH AND TREATMENT. vol. 100, S274-S275.
Duffy SW, McCann J, Godward S, Gabe R, Warwick J(2006). Some issues in screening for breast and other cancers. J Med Screen vol. 13 Suppl 1, S28-S34.
Gabe R, Duffy SW, Mackay J, Anderson E, Duffy S, Ellis T, Evans G, Fielder H et al.(2006). The challenge of evaluating annual mammography screening for young women with a family history of breast cancer. J MED SCREEN vol. 13, (4) 177-182.
10.1177/096914130601300404
Duffy SW, Smith RA, Gabe R, Tabár L, Yen AMF, Chen THH(2005). Screening for breast cancer. Surg Oncol Clin N Am vol. 14, (4) 671-697.
10.1016/j.soc.2005.06.001
Duffy SW, Gabe R(2005). What should the detection rates of cancers be in breast screening programmes?. Br J Cancer vol. 92, (3) 597-600.
10.1038/sj.bjc.6602345
Gabe R, Duffy SW(2005). Evaluation of service screening mammography in practice: the impact on breast cancer mortality. Ann Oncol vol. 16 Suppl 2, ii153-ii162.
10.1093/annonc/mdi718
Smith RA, Duffy SW, Gabe R, Tabar L, Yen AMF, Chen THH(2004). The randomized trials of breast cancer screening: what have we learned?. RADIOL CLIN N AM vol. 42, (5) 793-+.
10.1016/j.rcl.2004.06.014
Return to top